Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation)
Atlas Antibodies
- Catalog No.:
- ATL-HPA001032-25
- Shipping:
- Calculated at Checkout
$395.00
Gene Name: PDCD4
Alternative Gene Name: H731
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000024975: 98%, ENSRNOG00000014779: 98%
Entrez Gene ID: 27250
Uniprot ID: Q53EL6
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Product Specifications | |
Application | WB, IHC, ChIP-Exo-Seq |
Reactivity | Human, Mouse, Rat |
Clonality | Polyclonal |
Host | Rabbit |
Immunogen | VMSTTDVEKSFDKLLKDLPELALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATVLLSMSKGGKRKDSVWGSGGGQQSVNHLVKE |
Gene Sequence | VMSTTDVEKSFDKLLKDLPELALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATVLLSMSKGGKRKDSVWGSGGGQQSVNHLVKE |
Gene ID - Mouse | ENSMUSG00000024975 |
Gene ID - Rat | ENSRNOG00000014779 |
Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
Documents & Links for Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation) | |
Datasheet | Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation) at Atlas Antibodies |
Documents & Links for Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation) | |
Datasheet | Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation) |
Citations for Anti PDCD4 pAb (ATL-HPA001032 w/enhanced validation) – 9 Found |
Nicolè, Lorenzo; Cappellesso, Rocco; Sanavia, Tiziana; Guzzardo, Vincenza; Fassina, Ambrogio. MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma. Oncotarget. 2018;9(25):17300-17308. PubMed |
Ek, Sara; Andréasson, Ulrika; Hober, Sophia; Kampf, Caroline; Pontén, Fredrik; Uhlén, Mathias; Merz, Hartmut; Borrebaeck, Carl A K. From gene expression analysis to tissue microarrays: a rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Molecular & Cellular Proteomics : Mcp. 2006;5(6):1072-81. PubMed |
Mulder, Jan; Björling, Erik; Jonasson, Kalle; Wernérus, Henrik; Hober, Sophia; Hökfelt, Tomas; Uhlén, Mathias. Tissue profiling of the mammalian central nervous system using human antibody-based proteomics. Molecular & Cellular Proteomics : Mcp. 2009;8(7):1612-22. PubMed |
Baffa, Raffaele; Fassan, Matteo; Volinia, Stefano; O'Hara, Brian; Liu, Chang-Gong; Palazzo, Juan P; Gardiman, Marina; Rugge, Massimo; Gomella, Leonard G; Croce, Carlo M; Rosenberg, Anne. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. The Journal Of Pathology. 2009;219(2):214-21. PubMed |
Fassan, Matteo; Pizzi, Marco; Battaglia, Giorgio; Giacomelli, Luciano; Parente, Paola; Bocus, Paolo; Ancona, Ermanno; Rugge, Massimo. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. Journal Of Clinical Pathology. 2010;63(8):692-6. PubMed |
Fassan, Matteo; Pizzi, Marco; Giacomelli, Luciano; Mescoli, Claudia; Ludwig, Kathrin; Pucciarelli, Salvatore; Rugge, Massimo. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Archiv : An International Journal Of Pathology. 2011;458(4):413-9. PubMed |
Fassan, M; Realdon, S; Pizzi, M; Balistreri, M; Battaglia, G; Zaninotto, G; Ancona, E; Rugge, M. Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. Diseases Of The Esophagus : Official Journal Of The International Society For Diseases Of The Esophagus. 2012;25(3):263-8. PubMed |
Mian, Caterina; Pennelli, Gianmaria; Fassan, Matteo; Balistreri, Mariangela; Barollo, Susi; Cavedon, Elisabetta; Galuppini, Francesca; Pizzi, Marco; Vianello, Federica; Pelizzo, Maria Rosa; Girelli, Maria Elisa; Rugge, Massimo; Opocher, Giuseppe. MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid : Official Journal Of The American Thyroid Association. 2012;22(9):890-6. PubMed |
Galuppini, Francesca; Fassan, Matteo; Bertazza, Loris; Barollo, Susi; Cascione, Luciano; Watutantrige-Fernando, Sara; Lazzarin, Vanni; Simonato, Paolo; Vianello, Federica; Rugge, Massimo; Mian, Caterina; Pennelli, Gianmaria. Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma. Cancer Management And Research. 11( 31692513):7845-7855. PubMed |